Trial Profile
Impact of primary tumor localization on the survival of colorectal cancer patients treated with bevacizumab: A prospective cohort study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 08 Dec 2015 New trial record